Kdo2-Lipid A ammonium结构式
|
常用名 | Kdo2-Lipid A ammonium | 英文名 | Di[3-deoxy-D-Manno-octulosonyl]-lipid A (amMonium salt) |
---|---|---|---|---|
CAS号 | 1246298-62-3 | 分子量 | 2326.646 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C110H198N2Na4O39P2 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
Kdo2-Lipid A ammonium用途Kdo2脂质A铵是一种化学定义的脂多糖(LPS),其内毒素活性等同于LPS。Kdo2脂质A铵对TLR4具有高度选择性。Kdo2脂质A铵刺激TNF和PGE2的释放[1]。 |
中文名 | 二[3-脱氧-D-甘露聚糖-八磺酰基]-脂质A(铵盐) |
---|---|
英文名 | Tetrasodium 3-deoxy-6-[(1R)-1,2-dihydroxyethyl]hex-2-ulopyranonosyl-(2->4)-3-deoxy-6-[(1R)-1,2-dihydroxyethyl]hex-2-ulopyranonosyl-(2->6)-2-deoxy-2-{[(3R)-3-(dodecanoyloxy)tetradecanoyl]amino}-4-O-(hydroxyphosphinato)-3-O-[(3R)-3-(tetradecanoyloxy)tetradecanoyl]hexopyranosyl-(1->6)-2-deoxy-1-O-(hydroxyphosphinato)-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}hexopyranose |
英文别名 | 更多 |
描述 | Kdo2脂质A铵是一种化学定义的脂多糖(LPS),其内毒素活性等同于LPS。Kdo2脂质A铵对TLR4具有高度选择性。Kdo2脂质A铵刺激TNF和PGE2的释放[1]。 |
---|---|
相关类别 | |
靶点 |
TLR4 |
体外研究 | Kdo2脂质A(1µM)刺激成年大鼠脊髓星形胶质细胞培养物中TNF和PGE2的释放[1]。RT-PCR[1]细胞系:TNF和PGE2浓度:1µM培养时间:结果:TNF和PGE2的蛋白质(mg)含量分别为6.2±0.6 ng/mL和1.4±0.3 ng/mL。 |
体内研究 | KDO2脂质A(i.t.)激活大鼠的toll样受体4(TLR4)[1]。动物模型:大鼠(雄性Holzman-Sprague-Dawley,300-400克)[1]剂量:0.1至10微克给药:I.T。;0.1-10微克;结果:鞘内注射1µg Kdo2脂质A可引起痛觉超敏,注射Kdo2脂质A后动物出现疾病。 |
参考文献 |
分子式 | C110H198N2Na4O39P2 |
---|---|
分子量 | 2326.646 |
精确质量 | 2325.263672 |
外观性状 | 固体 |
储存条件 | 20°C |
Tetrasodium 3-deoxy-6-[(1R)-1,2-dihydroxyethyl]hex-2-ulopyranonosyl-(2->4)-3-deoxy-6-[(1R)-1,2-dihydroxyethyl]hex-2-ulopyranonosyl-(2->6)-2-deoxy-2-{[(3R)-3-(dodecanoyloxy)tetradecanoyl]amino}-4-O-(hydroxyphosphinato)-3-O-[(3R)-3-(tetradecanoyloxy)tetradecanoyl]hexopyranosyl-(1->6)-2-deoxy-1-O-(hydroxyphosphinato)-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}hexopyranose |
Hexopyranose, O-3-deoxy-D-glycero-2-octulopyranonosyl-(2->4)-O-3-deoxy-D-glycero-2-octulopyranonosyl-(2->6)-O--2-deoxy-2-[[(3R)-1-oxo-3-[(1-oxododecyl)oxy]tetradecyl]amino]-3-O-[(3R)-1-oxo-3-[(1-oxotetradecyl)oxy]tetradecyl]-4-O-phosphonohexopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3-hydroxy-1-oxotetradecyl]-2-[[(3R)-3-hydroxy-1-oxotetradecyl]amino]-, 1-(dihydrogen phosphate), sodium salt (1:4) |